Business Paid
Adamed Commits PLN 2bn to Boost Research and Production by 2030
13:20
Leading Polish pharmaceutical company, Adamed, has announced plans to invest nearly PLN 2 billion by the end of the decade to enhance its research and production capabilities.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
